We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

94 hedge funds and large institutions have $589M invested in Epizyme, Inc in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $450M → $589M (+$139M)

19% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 27

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $1.09M

3% less funds holding

Funds holding: 97 → 94 (-3)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

Holders
94
Holders Change
-3
Holders Change %
-3.09%
% of All Funds
2.35%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
9
Increased
32
Reduced
27
Closed
11
Calls
$1.09M
Puts
$1.09M
Net Calls
-$5K
Net Calls Change
+$842K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$13.7M
2
GTC
Ghost Tree Capital
New York
+$4.96M
3
State Street
State Street
Massachusetts
+$3.76M
4
PAI
Palo Alto Investors
California
+$2.31M
5
BFA
BlackRock Fund Advisors
California
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$3.34M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.77M
3
SCA
Secor Capital Advisors
New York
-$1.67M
4
IHM
Iguana Healthcare Management
New York
-$1.48M
5
Millennium Management
Millennium Management
New York
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$98.8M – – –
Primecap Management
2
Primecap Management
California
$79.2M +$188K +18,000 +0.3%
NMC
3
NEA Management Company
Maryland
$75.8M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$37.3M +$1.26M +120,701 +4%
PAI
5
Palo Alto Investors
California
$36.7M +$2.31M +221,256 +8%
BFA
6
BlackRock Fund Advisors
California
$24.4M +$2.26M +216,376 +12%
Jennison Associates
7
Jennison Associates
New York
$23.4M +$1.92M +184,069 +11%
MAM
8
MPM Asset Management
Massachusetts
$20.9M – – –
DM
9
Deerfield Management
New York
$19.4M +$13.7M +1,309,870 +450%
FCMI
10
Foresite Capital Management II
California
$18.5M -$172K -16,481 -1%
Franklin Resources
11
Franklin Resources
California
$14.1M -$386K -37,000 -3%
State Street
12
State Street
Massachusetts
$13.2M +$3.76M +359,859 +49%
BIT
13
BlackRock Institutional Trust
California
$11.7M +$1.05M +100,225 +12%
VOYA Investment Management
14
VOYA Investment Management
Georgia
$10.4M -$200K -19,121 -2%
CC
15
CQS Cayman
Cayman Islands
$7.67M – – –
FCMI
16
Foresite Capital Management III
California
$7.32M -$68.2K -6,538 -1%
RSCM
17
Rock Springs Capital Management
Maryland
$6.9M -$757K -72,500 -11%
QF
18
QVT Financial
New York
$6.42M -$3.34M -320,165 -38%
Northern Trust
19
Northern Trust
Illinois
$6.06M +$502K +48,109 +11%
Norges Bank
20
Norges Bank
Norway
$5.96M – – –
GTC
21
Ghost Tree Capital
New York
$5.75M +$4.96M +475,000 New
TCM
22
Tekla Capital Management
Massachusetts
$4.84M – – –
Geode Capital Management
23
Geode Capital Management
Massachusetts
$3.9M +$278K +26,627 +9%
CC
24
Casdin Capital
New York
$3.33M -$209K -20,000 -7%
EAM
25
Eventide Asset Management
Massachusetts
$3.33M – – –
1
2 3 4 5

EPZM Hedge Fund Activity: Q4 2016 in Review

94 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q4 2016, worth a combined $589M — up 31% from $450M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of EPZM and 9 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 32 added.

The largest buyer was Deerfield Management, adding an estimated $13.7M. The largest seller was QVT Financial, cutting an estimated $3.34M.

  • 94 institutional investors held Epizyme, Inc (EPZM) as of Q4 2016, down from 97 in Q3 2016.
  • Funds reported $589M of Epizyme, Inc stock for Q4 2016, up 31% quarter-over-quarter.
  • 9 funds opened new Epizyme, Inc positions in Q4 2016 and 11 closed out, a net change of -2 holders.
  • The largest Epizyme, Inc buyer in Q4 2016 was Deerfield Management, an estimated $13.7M added.
  • The largest Epizyme, Inc seller in Q4 2016 was QVT Financial, an estimated $3.34M sold.

Based on aggregated 13F filings for Q4 2016.